[S27] A New Frontier in Cancer Therapy: Exploring the Potential of At-211

10:36 AM - 10:52 AM JST(1:36 AM - 1:52 AM UTC)

[S27-2] Development and evaluation of At-211 labeled peptides

○Kazuma Ogawa^1,2 (1. INFINITI, Kanazawa Univ., 2. Grad. Sch. Pharm., Kanazawa Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.